RERCX
Price
$61.43
Change
-$0.14 (-0.23%)
Updated
Sep 18 closing price
Net Assets
140.03B
TIOHX
Price
$17.80
Change
+$0.27 (+1.54%)
Updated
Sep 17 closing price
Net Assets
2.61B
Interact to see
Advertisement

RERCX vs TIOHX

RERCX vs TIOHX Comparison Chart in %
View a ticker or compare two or three
VS
RERCX vs. TIOHX commentary
Sep 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RERCX is a StrongBuy and TIOHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERCX has more cash in the bank: 140B vs. TIOHX (2.61B). RERCX pays higher dividends than TIOHX: RERCX (2.38) vs TIOHX (1.85). RERCX was incepted earlier than TIOHX: RERCX (24 years) vs TIOHX (11 years). RERCX (1.12) is less costly to investors than TIOHX (0.68). TIOHX is a more actively managed with annual turnover of: 58.00 vs. RERCX (50.00). RERCX has a lower initial minimum investment than TIOHX: RERCX (250) vs TIOHX (100000). TIOHX annual gain was more profitable for investors over the last year : 4.42 vs. RERCX (1.53). TIOHX (-6.58) and RERCX (-6.70) have equivalent 5 years return.
RERCXTIOHXRERCX / TIOHX
Total Expense Ratio1.120.68165%
Annual Report Gross Expense Ratio1.120.68165%
Fund Existence24 years11 years-
Gain YTD5.0987.74866%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets140B2.61B5,364%
Annual Yield % from dividends2.381.85129%
Returns for 1 year1.534.4235%
Returns for 3 years25.8234.6774%
Returns for 5 years-6.70-6.58102%
Returns for 10 years41.1487.7647%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JETS28.220.05
+0.18%
U.S. Global Jets ETF (JETS)
TOCT27.23N/A
N/A
Innovator 2 Yr to October 2027 (TOCT)
CANC41.65-0.36
-0.86%
Tema Oncology ETF (CANC)
EASY26.33-0.25
-0.93%
Liberty One Defensive Dividend Growth ETF (EASY)
XBI156.72-1.53
-0.97%
State Street SPDR S&P Biotech ETF (XBI)